Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PrEP for HIV Prevention: Evidence, Global Scale-up, and Emerging Options
Connie Celum, Jared M. Baeten
Cell Host & Microbe (2020) Vol. 27, Iss. 4, pp. 502-506
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Prevalence of sexualized drug use and risk of HIV among sexually active MSM in East and South Asian countries: systematic review and meta‐analysis
Laura Nevendorff, Sophia Schroeder, Alisa Pedrana, et al.
Journal of the International AIDS Society (2023) Vol. 26, Iss. 1
Open Access | Times Cited: 24
Safety and efficacy of long-acting injectable cabotegravir as preexposure prophylaxis to prevent HIV acquisition
Virginia A. Fonner, Kathleen Ridgeway, Ariane van der Straten, et al.
AIDS (2023) Vol. 37, Iss. 6, pp. 957-966
Open Access | Times Cited: 24
Alignment of PrEP adherence with periods of HIV risk among adolescent girls and young women in South Africa and Zimbabwe: a secondary analysis of the HPTN 082 randomised controlled trial
Jennifer Velloza, Deborah Donnell, Sybil Hosek, et al.
The Lancet HIV (2022) Vol. 9, Iss. 10, pp. e680-e689
Open Access | Times Cited: 28
Long‐acting injectable cabotegravir forPrEP: A game‐changer inHIVprevention?
Geoffroy Liégeon, Jade Ghosn
HIV Medicine (2022) Vol. 24, Iss. 6, pp. 653-663
Open Access | Times Cited: 26
Safety and Tolerability of Once Daily Coformulated Bictegravir, Emtricitabine, and Tenofovir Alafenamide for Postexposure Prophylaxis After Sexual Exposure
Kenneth H. Mayer, Marcy Gelman, Johnathon Holmes, et al.
JAIDS Journal of Acquired Immune Deficiency Syndromes (2022) Vol. 90, Iss. 1, pp. 27-32
Closed Access | Times Cited: 22
PrEP policy implementation gaps and opportunities in Latin America and the Caribbean: a scoping review
Luke Murphy, Andrea Bowra, Ellithia Adams, et al.
Therapeutic Advances in Infectious Disease (2023) Vol. 10
Open Access | Times Cited: 12
Perspectives on Design Approaches for HIV Prevention Efficacy Trials
H Prudden, Roger Tatoud, Holly Janes, et al.
AIDS Research and Human Retroviruses (2023) Vol. 40, Iss. 5, pp. 301-307
Open Access | Times Cited: 10
Disclosure of oral pre-exposure prophylaxis use for HIV prevention among women enrolled in a contraceptive study: qualitative findings from Durban, South Africa
Ivana Beesham, Mags Beksinska, Cecilia Milford, et al.
Frontiers in Global Women s Health (2025) Vol. 5
Open Access
Analisis Pelaksanaan ART Dan PrEP Dalam Membendung HIV: Perspektif Syariah
Mohd Harifadilah Rosidi, Abdul Manan Ismail, Ahmad Wifaq Mokhtar
Journal of Fatwa Management and Research (2025) Vol. 30, Iss. 1, pp. 174-198
Closed Access
Associations with HIV preexposure prophylaxis use by cisgender female sex workers in two Ugandan cities
Richard Muhindo, Rachel King, Whitney C. Irie, et al.
PLoS ONE (2025) Vol. 20, Iss. 3, pp. e0320065-e0320065
Open Access
Efficacy estimates of oral pre-exposure prophylaxis for HIV prevention in cisgender women with partial adherence
Mia Moore, Sarah Stansfield, Deborah Donnell, et al.
Nature Medicine (2023) Vol. 29, Iss. 11, pp. 2748-2752
Open Access | Times Cited: 9
Factors influencing the uptake of a mono-PrEP implant for the prevention of HIV: Males’ perspectives from three South African provinces
Nqaba Mthimkhulu, Glory Chidumwa, Alison Kutywayo, et al.
PLoS ONE (2024) Vol. 19, Iss. 1, pp. e0296341-e0296341
Open Access | Times Cited: 3
High Levels of Prevention-Effective Adherence to HIV PrEP: An Analysis of Substudy Data From the EPIC-NSW Trial
Benjamin R. Bavinton, Stefanie Vaccher, Fengyi Jin, et al.
JAIDS Journal of Acquired Immune Deficiency Syndromes (2021) Vol. 87, Iss. 4, pp. 1040-1047
Closed Access | Times Cited: 19
Trust in the provider and accurate self-reported PrEP adherence among adolescent girls and young women in South Africa and Zimbabwe: HPTN 082 study
Geetha Beauchamp, Deborah Donnell, Sybil Hosek, et al.
BMC Women s Health (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 7
The wisdom of mistrust: qualitative insights from transgender women who participated in PrEP research in Lima, Peru
Amaya Perez‐Brumer, Sarah Naz‐McLean, Leyla Huerta, et al.
Journal of the International AIDS Society (2021) Vol. 24, Iss. 9
Open Access | Times Cited: 17
Perceptions of Pre-exposure Prophylaxis (PrEP) for HIV prevention among men living with HIV in the context of reproductive goals in South Africa: a qualitative study
Xolani Ntinga, Oluwaseyi O. Isehunwa, Lindani Msimango, et al.
BMC Public Health (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Trends in HIV incidence and mortality across Bharat (India) after the emergence of COVID-19
K.M. Varshney, A Mustafa
International Journal of STD & AIDS (2024) Vol. 35, Iss. 11, pp. 865-872
Closed Access | Times Cited: 2
Introducing the Dapivirine Vaginal Ring in Sub-Saharan Africa: What Can We Learn from Oral PrEP?
Neeraja Bhavaraju, Kathleen Shears, Katie Schwartz, et al.
Current HIV/AIDS Reports (2021) Vol. 18, Iss. 6, pp. 508-517
Open Access | Times Cited: 16
The Effect of Disclosure of PrEP Use on Adherence Among African Young Women in an Open-Label PrEP Study: Findings from HPTN 082
Geetha Beauchamp, Sybil Hosek, Deborah Donnell, et al.
AIDS and Behavior (2023) Vol. 28, Iss. 5, pp. 1512-1521
Open Access | Times Cited: 6
Effectiveness of PrEPTECH: Findings From a 180-Day Randomized Controlled Trial of a Pre-Exposure Prophylaxis Telehealth Intervention
Rebecca K Erenrich, Rebecca Braun, David M. Torres-Mendoza, et al.
JAIDS Journal of Acquired Immune Deficiency Syndromes (2023) Vol. 95, Iss. 5, pp. 463-469
Open Access | Times Cited: 5
Cabotegravir Extended-Release Injectable Suspension: A Review in HIV-1 Pre-Exposure Prophylaxis
Hannah A. Blair
Drugs (2022) Vol. 82, Iss. 14, pp. 1489-1498
Closed Access | Times Cited: 8
PrEP uptake and early persistence among adolescent girls and young women receiving services via community and hybrid community-clinic models in Namibia
Gena Barnabee, Idel Billah, Lylie Ndeikemona, et al.
PLoS ONE (2023) Vol. 18, Iss. 8, pp. e0289353-e0289353
Open Access | Times Cited: 4
Equipping providers to offer novel MPTs: Developing counseling messages for the Dual Prevention Pill in clinical studies and beyond
Kate Segal, Danielle M. Harris, Andy E. Carmone, et al.
Frontiers in Reproductive Health (2023) Vol. 5
Open Access | Times Cited: 3
Acceptability of an intravaginal ring for simultaneously preventing HIV infection and pregnancy: Qualitative findings of the Kisumu Combined Ring Study, 2019
Eleanor McLellan–Lemal, Stacie R. Deaton, Joshua E. Betts, et al.
Contemporary Clinical Trials (2022) Vol. 122, pp. 106935-106935
Open Access | Times Cited: 5
Use of simulated vaginal and menstrual fluids to model in vivo discolouration of silicone elastomer vaginal rings
Clare McCoy, Patrick Spence, Yahya H. Dallal Bashi, et al.
International Journal of Pharmaceutics X (2021) Vol. 3, pp. 100081-100081
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top